机构

• 上海药物研究所 [28]

采集方式

• OAI收割 [28]

内容类型

• 期刊论文 [28]

发表日期

• 2024 [1]
• 2023 [1]
• 2022 [2]
• 2021 [3]
• 2020 [2]
• 2019 [2]
• 更多

学科主题

筛选

浏览/检索结果: 共28条，第1-10条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序题名升序题名降序作者升序作者降序发表日期升序发表日期降序 Biotransformation and disposition characteristics of HSK7653, a novel long-acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes 期刊论文  OAI收割 DIABETES OBESITY & METABOLISM, 2024, 页码: 9 作者:  Bian, Yi-cong;  Meng, Jian;  Hu, Tao;  Ma, Sheng;  Huang, Chen-rong   |  收藏  |  浏览/下载：1/0  |  提交时间：2024/05/22 HSK7653  long-acting dipeptidyl peptidase-4 inhibitor  mass balance  metabolism  pharmacokinetics  radiolabelled   Orthogonally Engineered Albumin with Attenuated Macrophage Phagocytosis for the Targeted Visualization and Phototherapy of Liver Cancer 期刊论文  OAI收割 JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2023, 卷号: 145, 期号: 31, 页码: 17377-17388 作者:  Dou, Wei-Tao;  Qiu, Peng;  Shi, Yuanyuan;  Zhu, Ling;  Guo, Chen   |  收藏  |  浏览/下载：238/0  |  提交时间：2023/10/17 Aristolochic acids exposure was not the main cause of liver tumorigenesis in adulthood 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2022, 卷号: 12, 期号: 5, 页码: 2252-2267 作者:  Chen, Shuzhen;  Dong, Yaping;  Qi, Xinming;  Cao, Qiqi;  Luo, Tao   |  收藏  |  浏览/下载：27/0  |  提交时间：2022/08/16 Aristolochic acids (AAs)  Mutational signature  AA-DNA adduct  Hepatocellular carcinoma (HCC)  Liver tumorigenesis  Hepatitis B virus (HBV)  Risk factors  Tumor prevention   Fluorescent probes for the detection of disease-associated biomarkers 期刊论文  OAI收割 SCIENCE BULLETIN, 2022, 卷号: 67, 期号: 8, 页码: 853-878 作者:  Dou, Wei-Tao;  Han, Hai-Hao;  Sedgwick, Adam C.;  Zhu, Guo-Biao;  Zang, Yi   |  收藏  |  浏览/下载：27/0  |  提交时间：2022/08/16 Fluorescent probes  Fluorescence imaging  Biomarker detection  Chemical biology   Graphene nanoribbon-based supramolecular ensembles with dual-receptor targeting function for targeted photothermal tumor therapy 期刊论文  OAI收割 CHEMICAL SCIENCE, 2021, 页码: 9 作者:  Dou, Wei-Tao;  Xu, Fugui;  Xu, Chen-Xi;  Gao, Jie;  Ru, Hong-Bo   |  收藏  |  浏览/下载：25/0  |  提交时间：2021/08/17 A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia 期刊论文  OAI收割 Alzheimer's Research & Therapy, 2021, 卷号: 13, 期号: 1 作者:  Xiao,Shifu;  Chan,Piu;  Wang,Tao;  Hong,Zhen;  Wang,Shuzhen   |  收藏  |  浏览/下载：87/0  |  提交时间：2021/05/24 Sodium oligomannate  Efficacy  Safety  Alzheimer’s disease  Clinical trial   Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer's Disease at the Prodromal Stage 期刊论文  OAI收割 JOURNAL OF ALZHEIMERS DISEASE, 2021, 卷号: 83, 期号: 2, 页码: 779-790 作者:  He, Haining;  Liu, An;  Zhang, Wei;  Yang, Huanqing;  Zhang, Minmin   |  收藏  |  浏览/下载：34/0  |  提交时间：2021/11/04 Alzheimer's disease  biomarkers  microRNAs  mild cognitive impairment   A phase II randomized trial of sodium oligomannate in Alzheimer’s dementia 期刊论文  OAI收割 Alzheimer's Research & Therapy, 2020, 卷号: 12, 期号: 1 作者:  Wang,Tao;  Kuang,Weihong;  Chen,Wei;  Xu,Wenwei;  Zhang,Liming   |  收藏  |  浏览/下载：74/0  |  提交时间：2020/12/24 Sodium oligomannate  Efficacy  Safety  Alzheimer’s disease  Clinical trial   A phase II randomized trial of sodium oligomannate in Alzheimer's dementia 期刊论文  OAI收割 ALZHEIMERS RESEARCH & THERAPY, 2020, 卷号: 12, 期号: 1, 页码: 10 作者:  Wang, Tao;  Kuang, Weihong;  Chen, Wei;  Xu, Wenwei;  Zhang, Liming   |  收藏  |  浏览/下载：73/0  |  提交时间：2020/12/21 Sodium oligomannate  Efficacy  Safety  Alzheimer's disease  Clinical trial   Fluorescence imaging of a potential diagnostic biomarker for breast cancer cells using a peptide-functionalized fluorogenic 2D material 期刊论文  OAI收割 CHEMICAL COMMUNICATIONS, 2019, 卷号: 55, 期号: 88, 页码: 13235-13238 作者:  Dou, Wei-Tao;  Liu, Li-Fang;  Gao, Jie;  Zang, Yi;  Chen, Guo-Rong   |  收藏  |  浏览/下载：22/0  |  提交时间：2020/07/01